Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Overall Survival and Progression Free Survival of Patients With Large Cell Neuroendocrine Lung Cancer and Combined Large Cell Neuroendocrine Lung Cancer Treated in Clinical Stage I-IV

NCT03998332 is registered in ClinicalTrials.gov with Jaroslaw B. Cwikla, MD, PhD, Professor UWM as lead sponsor.

NCT NCT03998332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03998332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Overall Survival and Progression Free Survival of Patients With Large Cell Neuroendocrine Lung Cancer and Combined Large Cell Neuroendocrine Lung Cancer Treated in Clinical Stage I-IV
Lead sponsor
Jaroslaw B. Cwikla, MD, PhD, Professor UWM
Phase
Observational
Overall status
Completed
Start date
January 1, 2002
Completion date
December 31, 2018
Enrollment
132 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

survival outcomes of patients with pulmonary lcnec